Epstein-Barr virus related carcinoma

Clinical trials for Epstein-Barr virus related carcinoma explained in plain language.

Never miss a new study

Get alerted when new Epstein-Barr virus related carcinoma trials appear

Sign up with your email to follow new studies for Epstein-Barr virus related carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New drug targets virus to fight rare cancer

Disease control Ongoing

This phase 2 trial tests a drug called VK-2019 in 13 patients with Epstein-Barr virus (EBV)-positive nasopharyngeal cancer that has returned or spread and has no standard treatment. VK-2019 works by blocking a key viral protein, EBNA1, which the virus needs to survive. The main g…

Matched conditions: EPSTEIN-BARR VIRUS RELATED CARCINOMA

Phase 2 • Sponsor: Stanford University • Aim: Disease control

Last updated Jun 27, 2026 14:03 UTC

Epstein-Barr virus related carcinoma

Get alerted when new Epstein-Barr virus related carcinoma trials appear

New drug targets virus to fight rare cancer